AGLE
Aeglea Biotherapeutics, Inc.
Novartis Bioventures Ltd bought $3.0M of Aeglea Biotherapeutics, Inc.
10% owner
Bought$3,000,000
$10.00Price
300,000Shares
+15%Stake
What AGLE did for a copier
Prices for AGLE after this filing aren't in yet.
Novartis Bioventures Ltd's record
3 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Apr 12. Filed Tue, Apr 12, 1:09 PM ET, during the session. Not investment advice.